What Analysts Are Saying About Cerence Stock
Portfolio Pulse from Benzinga Insights
Analysts have varied ratings for Cerence (NASDAQ:CRNC) over the last quarter, with all ratings being indifferent. The average 12-month price target has significantly decreased from $10.25 to $5.0. Analysts from Evercore ISI Group, Baird, and Goldman Sachs have all lowered their price targets for Cerence, reflecting a bearish sentiment. Cerence has faced a decline in revenue and struggles with profitability, as indicated by its negative net margin, ROE, and ROA.
August 09, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have lowered their price targets for Cerence, with the average 12-month target dropping from $10.25 to $5.0. The company faces a decline in revenue and struggles with profitability, as indicated by its negative net margin, ROE, and ROA.
The significant reduction in price targets by multiple analysts and the company's financial struggles, including a decline in revenue and negative profitability metrics, suggest a bearish outlook for Cerence in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100